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Information in practice
Creative use of existing clinical and health outcomes data
to assess NHS performance in England: Part 2—more
challenging aspects of monitoring
Azim Lakhani, James Coles, Daniel Eayres, Craig Spence, Colin Sanderson
In the second of their two articles about using existing routine data to assess performance in the
NHS, the authors make practical suggestions about using data for mental health care, potentially
avoidable deaths, and forecasting coronary heart disease outcomes, and raise issues about
assumptions and technical aspects for discussion
There have been recent calls for better data on NHS
outputs and outcomes in England.1–4 However, this will
require new data collection that could take several
years. In the meantime, creative and informed use of
existing data, with clear admission of the known short-
comings, may give some indication of how outcomes
are changing.5 The main challenges are to measure
health validly and to judge how much any improve-
ments are due to NHS interventions.
In this, the second of our two articles, we explore
some of the technical issues involved and make
practical illustrative suggestions about how best to use
existing data regarding mental health care, potentially
avoidable deaths, and forecasting coronary heart
disease outcomes.6 Many other quality indicators could
be produced along similar lines.7
Suggestions for indicators illustrating a
range of methodological issues
Patterns of mental health care
Monitoring the quality of mental health care is
problematic. Case fatality rates are low, so indicators
based on numbers of deaths are inadequate. Much of
mental health care occurs outside hospital without
direct data on activity or outcomes. Also, there are few
explicit standards. The challenge is to find a way of
using data from hospitals to make some inferences
about both hospital and community care and to
identify aspects of care that are materially below
optimum.
The national service framework for mental health
highlights the preference for community over hospital
care.8 With this policy being expected to produce bet-
ter outcomes, assessing the way the service for mental
health is delivered may be used as a proxy for quality
of care. Mentally ill patients vary in numbers of
readmissions to hospital and cumulative lengths of
stay, and these may reflect variations in the quality and
availability of care and support in the community. Too
many readmissions and long cumulative lengths of
stay may reflect inadequate community care, but too
few readmissions and short cumulative lengths of stay
may reflect inadequate provision of necessary hospital
care.
A combination of the total number of admissions
and the total time spent in hospital by patients during
a year could be used to assess this. There may well be a
trade-off between time spent in hospital and frequency
of admission, and it is therefore important to consider
the balance between the two variables as well as the
individual measures. Studies of observed variation
between populations could be used to derive target
ranges for acceptable patterns of care.
To test this approach, we followed individual
patients aged 17-64 admitted to hospital in April of
each year in mental health specialties throughout the
financial year, using continuous inpatient spells and
the linkage methods described in our first article.6 We
calculated the total length of inpatient stay per person
during the year and the total number of admissions per
person during the year. Readmissions could be to any
NHS hospital in England and for any condition, such
as injury, not just mental illness. We attributed the val-
ues to the primary care organisation that covered the
patient’s place of residence at the time of first
admission.
We found substantial variation between primary
care organisations for each of the two variables. To give
each component equal weight, we transformed them
into z scores (by measuring distance from their
reference points and dividing by the standard
deviations of the individual distributions). Convention-
ally, the mean of a distribution is the reference point
for z scores. However, the mean is not necessarily a
suitable target for a performance score because it is
partly a reflection of “poor performance” at the tail end
of the distribution.9 We used modified z scores in which
the reference points were 1.65 admissions per person
and 45.0 days total stay in hospital during the year. We
chose these points as a realistic joint target because
Extra technical details of the methods described appear on
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they had been achieved by a strategic health authority
in 2000-1 (the year selected as standard). This
“best achieved combination” of a low rate of
admissions per person and a low total stay per person,
giving each the same level of importance, equates to
the lowest composite z score at the level of strategic
health authority (see Year 3 in table 1), although at the
level of primary care organisation, some trusts
achieved even better z scores. We used these reference
points to calculate modified z scores across all five
years.
The z scores measure how far each primary care
organisation is from the defined optimum for total
admissions and for total stay. We then produced a
composite score for each organisation by adding its
two z scores, equating to a summary of that
organisation’s mix of experience on two fronts. A high
composite score would be considered undesirable as it
would indicate more hospitalisation than expected.
Weighting the z scores before adding them would be a
refinement if there was particular concern about the
relative importance of the two variables.
Figure1 shows modified z score isolines at primary
care organisation level. Two organisations with a
different mix of values for admissions and length of
stay may have the same composite z score, reflecting
the same performance but different trade-offs.
Improvement over time should lead to lower overall
composite z scores and a reduction in variation. Table
1 shows non-significant worsening trends in compos-
ite z scores at the England level and variation by stra-
tegic health authority for each of five financial years.
Caution is needed in interpreting these trends
because of the substantial recent organisational
change in mental health services and disruptions to
data collection. However, our analyses show the feasi-
bility of examining patterns of care, rather than focus-
ing on a single variable. The indicator could be refined
further by standardising for diagnostic mix, subject to
development and testing.
A possible cause of variation between primary care
organisations might be differences in the prevalence
of illness and in the level of support provided in the
community, both by professional bodies and informal
networks such as families. A full assessment of the
effect of such factors is beyond the scope of this
article, but we examined whether variation might be
reduced when looking at similar geographical areas.
For example, the populations of big cities can be more
transient, have a greater incidence of some mental ill-
nesses, and have fewer informal networks. The Office
for National Statistics has used cluster analyses to
create an area classification for grouping primary care
organisations that are most similar in terms of 42
demographic, socioeconomic, housing, and other
Census 2001 variables.10 Figure 2 shows the composite
modified z score for each primary care organisation
grouped within its area group. Although it shows
some differences between groups (a slowly increasing
z score across the chart), there is much greater residual
variation within each group, suggesting that influences
other than demography and socioeconomic condi-
tions are largely responsible for the variation, such as
service availability and clinical practice.
A measure of wider population mortality
attributable to health care
Attempts to assess the contribution of health services
to the entire population (not just those using health
services) have relied on population based indicators of
potentially avoidable mortality. Causes of death are
included if there is evidence that they are amenable
to healthcare interventions and—given timely, appro-
priate, and high quality care—death rates should be
low among the age groups specified.11 Healthcare
intervention includes preventing disease onset as well
as treating existing disease.
Two such indicators based on potentially avoidable
mortality are published annually for the NHS in the
Compendium of Clinical and Health Indicators.7 Nolte and
McKee reviewed the use of this concept and proposed
an updated list of conditions and age bands for
international comparisons, based on more recent
evidence of amenability to healthcare interventions.12
We have used their list but have added asthma at ages
0-44 years, which they excluded because of lack of
comparability in international studies.
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Fig 1 Combined z score isolines and results for individual primary
care organisations for measures of mental health care—total length
of inpatient stay per person and total number of admissions per
person for patients aged 17-64 years admitted to hospital in mental
health specialties in financial year 2002-3. (Excludes organisations
with <20 patients admitted in April)
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Fig 2 Combined z scores of individual primary care organisations
grouped by Office for National Statistics (ONS) area classification for
patients aged 17-64 years admitted to hospital in mental health
specialties in financial year 2002-3. (Excludes organisations with <20
patients admitted in April)
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In England 138 346 such deaths occurred in
people aged less than 75 during 2001 and 2002, of
which 48% were from ischaemic heart disease, 16%
from cerebrovascular disease, 9% from colorectal
cancer, 9% from female breast cancer, and 6% from
pneumonia.
Table 1 shows the trend and geographical variation
in deaths that were amenable to healthcare interven-
tions and those that were not in people aged less than
75 years during 1998-2002. Mortality from amenable
causes (including ischaemic heart disease) fell from
164 to 132 per 100 000—an average annual improve-
ment of 5.7%. Mortality from ischaemic heart disease
improved by an average of 6.5% a year, and mortality
from other amenable causes improved by 5.0% a
year. This compares with an annual improvement of
only 1.0% for mortality from causes not considered
amenable.
Figure 3 shows the trends for the 10 year period
1993-2002. There is a discontinuity in the trends as a
result of a change in 2001 from ICD-9 to ICD-10 for
coding cause of death. The difference between amena-
ble and non-amenable causes in their improvement in
mortality suggests improvements in the effectiveness
of health care. The main concern about this approach
is that trends and geographical variation may partly be
due to factors other than the quality of health care, in
particular improving socioeconomic conditions.
Forecasting future outcomes attributable to current
investments
The observation that today’s survival and death rates
are at least partly a reflection of the quality of earlier
health care applies particularly to primary and second-
ary prevention of conditions such as heart disease,
stroke, diabetes, some cancers, and diseases of
childhood. The converse of this is that many of the
benefits to health from improved care today will not be
seen for many years. One of the implications of this is
that a comprehensive assessment of the quality of a
healthcare system should include formal forecasts of
the longer term effects of recent changes in provision
and activity.
Table 1 Values for suggested NHS performance indicators in England over five financial or calendar years
Outcome
Financial or calendar year
Trend for average annual
improvement*
Year 1 Year 2 Year 3 Year 4 Year 5 (95% CI) % R2 P value
Patterns of mental health care†
No of admissions in April 7 335 8 020 7 163 8 295 8 095
Composite z score:
England 1.99 2.38 2.29 2.50 2.53 {5.4 0.750 0.058
SHA minimum 0.43 0.07 0.00 1.07 0.55
SHA maximum 5.37 5.52 6.72 4.26 6.97
Population mortality from ischaemic heart disease‡
No of deaths 41 478 38 598 35 991 34 200 32 257
Death rate/100 000:
England 79.9 74.1 68.9 65.2 61.0 (60.4 to 61.7) 6.5 0.997 <0.001
SHA minimum 56.8 52.8 46.6 46.0 45.1 (41.8 to 48.7)
SHA maximum 110.2 100.6 92.2 90.4 84.3 (80.7 to 87.9)
Population mortality from causes amenable to health care, including IHD§
No of deaths 83 821 80 852 76 648 70 439 67 907
Death rate/100 000:
England 164.4 158.3 149.7 137.2 131.5 (130.5 to 132.5) 5.7 0.982 0.001
SHA minimum 126.9 120.5 116.5 105.1 103.7 (98.2 to 109.1)
SHA maximum 214.5 203.0 187.9 177.5 169.8 (164.7 to 174.9)
Population mortality from causes amenable to health care, excluding IHD§
No of deaths 42 343 42 284 40 657 36 239 35 650
Death rate/100 000:
England 84.5 84.2 80.9 72.1 70.5 (69.7 to 71.2) 5.0 0.893 0.015
SHA minimum 69.9 66.4 67.1 59.1 58.4 (54.2 to 62.6)
SHA maximum 104.4 104.2 95.7 88.6 85.5 (81.8 to 89.2)
Population mortality from causes not amenable to health care¶
No of deaths 108 229 106 715 104 922 105 808 105 888
Death rate/100 000:
England 215.4 212.0 207.8 208.5 206.9 (205.6 to 208.2) 1.0 0.848 0.026
SHA minimum 182.4 172.2 177.9 174.3 177.5 (170.3 to 184.7)
SHA maximum 265.6 260.0 254.5 252.2 246.6 (238.6 to 254.6)
IHD=Ischaemic heart disease. SHA=Strategic health authorities (as at April 2003).
*Fitting a linear trend to log transformed rates.
†Composite z score for total number of admissions and total length of stay per person for those organisations with at least one admission in April, compared with
the best performance among strategic health authorities in 2000-1, for financial year 1998-9 to 2002-3. (Data source: hospital episode statistics.)
‡Deaths from ischaemic heart disease among residents aged <75 years for 1998-2002 (ICD-9 codes 410-414 in years 1998-2000, ICD-10 codes I20-I25 in years
2001-2). Death rates directly standardised for age using the European standard population. Data based on ICD-9 are not adjusted for equivalence to ICD-10. (Data
source: Office for National Statistics.)
§Deaths from causes considered amenable to health care among residents aged <75 years for 1998-2002 (various ICD codes for specific age groups, ICD-9 codes in
years 1998-2000, ICD-10 codes in years 2001-2). Death rates directly standardised for age using the European standard population. Data based on ICD-9 are not
adjusted for equivalence to ICD-10. (Data source: Office for National Statistics.)
¶Deaths from causes not considered amenable to health care among residents aged <75 years for 1998-2002. (Use of ICD codes, standardisation of death rates, and
data source as above.)
See BMJ.com for further details on indicators.
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Several mathematical models have been and are
being developed for doing this. For example, long term
relative survival can be predicted for patients with
recently diagnosed cancer.13 Another example is a
microsimulation model that provides estimates of the
annual benefits and costs over the middle and longer
term (up to 20 years) of different patterns of healthcare
provision and use for coronary heart disease.14 In
terms of primary prevention, the model allows
exploration of the population effect of improvements
in the control of blood pressure and cholesterol and of
changes in rates of cigarette smoking. In terms of treat-
ment, it can explore the effects of changing ambulance
response times, thrombolysis, and revascularisation
rates. The model can produce, for example, estimates
of the likely impact of meeting national service frame-
work activity targets for coronary heart disease. Tables
2 and 3 show some illustrative examples of this,
extracted from a report on this developmental work to
the Department of Health,14 to demonstrate how simu-
lation could be used to inform policy, subject to various
assumptions and constraints.14 Currently, the model is
being extended to other clinical conditions such as
stroke and diabetes. Such models could be used to
show the likely impact of new investments in
prevention, incremental shifts from treatment to
prevention, or alternative mixes of interventions.
Models of this kind are inevitably very demanding
of data and assumptions, and there may be a trade-off
between rigour and transparency. Their requirements
include estimates of baseline levels of risk factors,
disease prevalence, and healthcare use; estimates of
trends over the forecasting period in exogenous
factors (those not determined within the model); and,
for cost effectiveness analyses, estimates of how
treatment costs vary as levels of activity change. As well
as modelling relationships between risk factors and
outcomes, they have to be able to deal with
combinations of changes in risk factors (such as reduc-
ing blood pressure and cholesterol concentrations)
and interactions between risk factors (such as the effect
of stopping smoking on blood pressure). Management
of heart disease is one of the best researched aspects of
health care, and, as well as the scientific literature, this
model is based on new analyses of data from the health
survey for England, the Framingham cohort study, and
the British heart survey.14 However, different studies
define variables in different ways, and substantial gaps
in the literature remain, such as the effects of stopping
treatment. Also, such models need maintenance, with
new research findings needing to be incorporated
regularly.
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Table 2 Use of simulation model to show how coronary heart disease outcomes are likely to change after implementation of service
targets specified in the national service framework: prevention model*
Results of simulation Stable angina Myocardial infarction
Sudden cardiac
death Stroke death
Other death from
cardiovascular
disease
No of events in baseline† 197.0 140.2 43.8 12.1 10.4
% reduction in first events in 10 years after
intervention‡
6.55 6.95 10.86 2.90 5.77
*Target level of intervention is more systematic identification, assessment, treatment, and follow up of people at risk of coronary heart disease—that is, known
patients who cross the blood pressure threshold are assessed within a year, and if no treatment is indicated the recall period is reduced to a year; the uptake of
cholesterol treatment, where indicated, is increased to 100%. (These results are very sensitive to assumptions about background trends in baseline risk factors.)
†Baseline is 1998, before national service framework, among 6923 respondents aged 35-85.
‡Events in those aged 45-85 years (that is, 10 years older) after intervention (20 iterations of the model over 10 years).
Table 3 Use of simulation model to show how coronary heart disease (CHD) outcomes are likely to change after implementation of
service targets specified in the national service framework: treatment model*
Results of simulation† No of CHD patients Life years saved
Deaths from all causes Cost per life year
savedNo of deaths No prevented
Baseline 30 843 — 2302 —
After intervention (20 iterations of model
over 20 years)
32 603‡ 1759 2109 193 £4998
*Combined target levels of intervention (with no assumptions about any interaction between them): Revascularisation capacity increased to 3120 angiograms per
million population and 1500 angioplasties and bypass grafts combined per million population; Secondary prevention drugs (aspirin, statins, ACE inhibitors, 
blockers) provided to 90% of patients, allowing for contraindications; Cardiac rehabilitation offered to 85% of patients having bypass surgery, angioplasty, or
myocardial infarction; Ambulance response times reduced to 75% within 8 minutes for myocardial infarction and cardiac arrest calls; Thrombolysis door-to-needle
time reduced to 30 minutes for 75th centile of distribution for patients eligible for thrombolysis (excluding 10% who fail to receive thrombolysis at all).
†Events per year in a population of 1 million.
‡Increase in CHD patients is due to the reduction in case fatality.
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For discussion and debate
Our two articles are confined to health outcome meas-
ures and their proxies. There are, however, many other
types of outputs that could be included in assessments
of productivity. The following issues and assumptions
require further discussion.
Selection of indicators and targets
Attribution of changes in health status to healthcare
activity would normally require experimentation such
as randomised controlled trials. Since this is not
feasible as part of routine delivery of health services,
judgment must be used, based on three criteria:
x Research evidence or consensus (expressed in poli-
cies) suggest that health services (including public
health, health partnerships, health advocacy) can have
a significant influence on the outcome being measured
x Variation between organisations in current per-
formance suggests scope for improvement, with the
best showing what is realistically achievable given opti-
mum circumstances9
x Variation between organisations in changes in
performance over time suggests scope for improve-
ment, with the greatest improvement showing what is
realistically achievable given optimum circumstances.
The first criterion is essential for selection of
indicators. The other two may not be, as the services
may already be performing at an optimal level. Even if
all three criteria are met, the outcomes may still reflect
interventions not attributable to health services.
Aspects such as quality of life may be of more con-
cern to patients than clinical measures, and therefore
more appropriate as measures of outcome, albeit with
greater problems of attribution. Absence of routine
data on health related quality of life is a serious gap in
our knowledge.
For annual cross sectional monitoring, it is impor-
tant to select indicators that reflect short term impact
unless long term impact is clear or can be forecast.
Indicators such as incidence of stroke and deaths may
reflect the cumulative effect of several natural events
and interventions or resource use in the past. Some of
these, such as prevalence of obesity and high blood
pressure, may also act as proxies for future adverse
outcomes and may therefore have a dual role in annual
cross sectional monitoring.
Where there is clear evidence of the relation
between intervention and health, such evidence may
be used to create explicit standards for performance
audit, and measures of the level of intervention may be
used as proxies for future outputs or health outcomes.
Table 4 shows that the measure of what is
achievable depends on the level at which analysis is
undertaken. In large populations (regions, strategic
health authorities) indicators are likely to be stable but
may mask the true “optimum.” Smaller populations
(primary care organisations, local authorities) will
have fewer events and more inherent variability, and
extreme values may reflect atypical circumstances. The
reference point that is ultimately selected will be a
matter of judgment, as not all events being measured
(admissions, readmissions, deaths, etc) are likely to be
avoidable. What we are seeking, in the absence of an
evidence based standard, is an aspirational target
based on reality, towards which we would expect the
NHS to be moving. In some cases, this could be
informed by what is shown to be achievable in
international studies, as has been suggested for cancer
survival.
Methodology
Ideally, numerators and denominators should match—
for example, case fatality rates for stroke should be
based on all deaths among all patients with stroke,
including those not admitted to hospital and who may
have either mild disease with lower case fatality or
severe disease and death before admission. This is not
always possible, and the limitations of what is feasible
must be acknowledged. Some indicators measure what
happens to known patients, with a risk that those
needing care but not receiving it, possibly with poorer
outcomes, are excluded.
Any measure of geographical variation or time
trends needs to ensure comparability of numerator
and denominator data. This may require adjustment of
indicators for differences in age, sex, case mix (mix or
severity of conditions), etc. A major constraint with
existing routinely collected national data is the lack of
grouping systems for case mix that are based on prog-
nosis. Grouping systems, such as healthcare resource
groups, were designed to create subgroups for
comparison that are homogeneous with respect to
resource use but not necessarily outcomes. Standardi-
sation also raises questions about what adjustment is
legitimate. People in deprived populations might have
relatively poor outcomes because of relatively intracta-
ble health problems or because of substandard care, or
both. Standardisation is undiscriminating and would
“protect” the providers against both kinds of effects.
Likewise, where there is sex variation, there is a choice
between using sex standardised person rates or sex
specific rates.
Table 4 Mortality from causes considered amenable to health care by organisational level, England 2001-2
Organisational level
No of organisational
units
Total population range
(1000s)
Standardised mortality*
Mean (range)
Centiles
10th 50th 90th
England 1 49 646 134.4
Government office region 9 2538-8044 136.1 (114.0-157.9)
ONS area group 12 1428-12 154 139.9 (104.2-170.3)
Strategic health authority 28 1146-2651 134.7 (104.4-173.7) 114.4 130.9 161.9
Local authority 354 25-990† 128.5 (0.0-223.8) 98.6 124.1 168.3
Primary care organisation 303 65-373 134.7 (84.4-259.9) 103.0 129.9 175.7
*Directly standardised for age (using the European standard population) per 100 000 people aged 0-74 years.
†Excluding Isles of Scilly and City of London.
(Data sources: Office for National Statistics, Department of Health.)
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When standardising rates for age (and other
variables) the choice of method (direct or indirect) and
of the standard population used may affect the results,
particularly when comparing sub-national rates. We
tested this for hospital case fatality, calculating trends at
the England level using both direct and indirect meth-
ods and using various years as the standard, and found
little difference (table 2, part 16). However, this should
be monitored in any new approach to measuring per-
formance. For the correct analysis of trends, data for all
years should be adjusted with the same standard and
time period.
The stability of the indicator needs to be taken into
account. For example, data on strategic health authori-
ties are less prone to yearly fluctuations in rankings
than data on primary care organisations because of
their larger populations.
Interpretation of data
Variation in data quality (in levels of missing records
and missing or invalid codes) could influence trends,
particularly if there were biases in such records
compared with the rest. In the extra technical material
on bmj.com, table 1.1 shows that the levels of
incompleteness for indicators based on hospital
episode statistics are too small to affect England
indicator values and do not vary much between years.
Within each year, however, completeness varies by
strategic health authority, requiring caution in inter-
preting comparative strategic health authority data.
The accuracy of seemingly valid diagnostic codes has
been a source of concern.15 There are now local routine
audits of the quality of clinical coding (personal
communication, NHS Information Authority) but no
national reporting system, which remains a serious
gap.
National aggregate values may mask variation
in component parts that could be important for
productivity assessment. Table 2.2 in the extra techni-
cal material on bmj.com shows that there are age and
sex specific variations in hospital case fatality and
varying time trends. For example, there is convergence
between sexes in the 0-5 year old age group over the
five years but persistent sex differences in the 60-64
year age group. There are falling trends in deaths in
the 75-79 year group but not in the 45-49 year group.
The potential for competition for resources
between types of care and conditions needs to be
acknowledged at national and local level, because the
“best” achieved in one locality for one indicator may
have been at the expense of poorer performance in
other aspects of health care, reflecting local priorities.
Most service based indicators are incomplete, as
data from the independent healthcare sector are
missing.
Geographical monitoring is useful, as data can then
be interpreted in the context of the strategic roles of
strategic health authorities, the commissioning roles of
primary care organisations, and local demographic
and socioeconomic conditions. Local conditions may
explain (although should not justify) poorer outcomes
if there are known effective interventions. We found
variations (some statistically significant) both between
and within the area groups created by the Office for
National Statistics for grouping healthcare organisa-
tions that are most similar in terms of a range of
demographic and socioeconomic conditions. Signifi-
cant variation within these groups probably reflects
influences other than demography and socioeconomic
conditions, such as quality of health care.
Application in productivity assessment
Practical ways need to be found to incorporate
multiple indicators in productivity assessment: they
may overlap or interact; some may be more important
or relevant than others and may need to be weighted;
some may reflect mismatching performance for a
given time (see the above discussion on stroke).
Techniques for dealing with these issues, such as
weighted scores, profiles, etc, are beyond the scope of
our two articles but need consideration.
High levels of activity in treatment, rehabilitation,
and long term care may show desirable high
productivity and improvement, but would be consid-
ered an undesirable or negative output of preventive
activity for a preventable condition such as stroke.
A cross sectional approach does not take account
of sequentially linked events over time, such as patients
with myocardial infarction having further infarcts in
due course.
Reality is even more complex than the approach
taken here, and this should be acknowledged explicitly
in any output to avoid sweeping simplistic generalisa-
tions during interpretation.
Conclusions
We have shown the feasibility of a variety of ways of
measuring health related outputs and outcomes. Data
from initiatives such as the new mental health
minimum dataset and the new general practice
contract should lead to better measurement. Any
assessment of productivity requires careful matching of
outcomes to the inputs used to achieve them, and this
brings in a separate set of issues and assumptions that
are beyond the scope of our articles.
AL’s contributions to the study were made within his role at the
Oxford branch of the National Centre for Health Outcomes
Development, based at Oxford University, Headington, Oxford.
Contributors: AL conceived of the study, drafted the article, and
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helped draft the article and produced the mental health indica-
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mortality indicators. CSp analysed hospital episode statistics
data. CSa helped draft the article and produced the forecasting
Summary points
More rigorous analysis of existing routine clinical
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What’s your motivation?
“Your salary’s your motivation.” So said director
Roman Polanski to Faye Dunaway when she asked him
about her character’s motivation in the film Chinatown.
But when motivating ourselves and others to learn,
should we take this approach too? Motivation is a
fundamental factor in nearly everything that we do—be
it going to work, learning, or going home in the
evenings. So when deciding what learning you are
going to do for yourself or arrange for others, you
should look critically at motivation. If you don’t your
learners could become what Michael Barber calls the
“disappointed, disillusioned, and disappeared.” He was
referring to the large numbers of adults in Britain who
have done little or no formal learning in the past four
years.1
Motivation can be intrinsic or extrinsic: an intrinsic
source would be curiosity or enjoying learning for its
own sake, and extrinsic motivation can be neatly
summarised as either a carrot or a stick.1 Both forms of
motivation are important, but if we want to encourage
lifelong learning then we should try to tip the scales
towards intrinsic motivation: rewards and negative
consequences come and go, but intrinsic factors seem
to last longer. In fact, too much emphasis on external
rewards or punishments can undermine intrinsic
motivation.
So how do we encourage intrinsic motivation? If
people feel that they are in control of their own
learning and feel confident that they have the tools to
learn then they will be more likely to stick with the task
in hand. Goals that they set themselves can also be
powerful motivators. Positive feedback can also
encourage motivation to learn. These factors have
been known about for some time and teachers and
learners have long been putting them into action. So,
you may ask, why do any learners still become
“disappointed, disillusioned and disappeared”?
Some of the answers lie in obstacles to motivation.
Getting started is one of the biggest obstacles. Doctors
are often procrastinators—they have heard of a course
or module that they want to do, and it has been in the
back of their minds for weeks. But taking the first step
is the hardest. In this regard, the classroom has got a
head start on e-learning. There is a degree of
compulsion involved in going to a course when you
said you would—even if it is only simple politeness. It
seems rude not to turn up, especially if only a few
people are attending and your absence will be noted.
Another obstacle is time—many people would love
to spend more time learning, but clinical work and
families come first. This is where e-learning has an
edge: you can learn in your time, at your own pace, and
in your own workplace or home. And if we are honest
with ourselves what is our real motivation to attend
courses? Is it an escape from work or a holiday? For
many trainers and trainees, training is seen as a perk or
a reward for hard work. But shouldn’t we be
encouraging people who are not high achievers to go
to courses?
All this has led to a radical rethink in the way that
teachers teach and learners learn. At BMJ Learning we
have tried to give as much power to the learner as
possible. Learners can learn in their own workplace
and at their own time. There is no “Big Brother”
watching—we don’t track learners’ use of the site. We
also allow all modules to be shared—all users can use
all the modules on the site whether they are general
practitioners or consultants. To encourage learners to
take their first step into e-learning, we made the first
modules fairly easy. But now that users have got started
we have upped the ante.
One of the most recent modules looks at nutrition in
critically ill adults. Do you know the difference between
hypocaloric, eucaloric, and hypercaloric feeding? Do
you know the electrolyte disturbances that suggest the
refeeding syndrome? Would you spot a feeding tube in
the right bronchus? To find out, have a look on
www.bmjlearning.com.
Kieran Walsh clinical editor, BMJ Learning
(bmjlearning@bmjgroup.com)
1 Epic Group. White paper: Motivation in e-learning. www.epic.
co.uk/content/resources/white_papers/motivation.htm (accessed
15 June 2005).
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